N-terminal cysteinyl proteins can be prepared using thrombin cleavage  by Liu, Dongsheng et al.
FEBS Letters 582 (2008) 1163–1167N-terminal cysteinyl proteins can be prepared using thrombin cleavage
Dongsheng Liu, Rong Xu, Kaushik Dutta, David Cowburn*
New York Structural Biology Center, 89 Convent Avenue, New York, NY 10027, USA
Received 4 September 2007; revised 26 November 2007; accepted 29 February 2008
Available online 10 March 2008
Edited by Christian GriesingerAbstract Expressed protein ligation – which allows native pro-
teins to be selectively linked together by a normal peptide bond in
an aqueous environment – has emerged as a powerful technique.
The technique requires the formation of a C-terminal a-thioester
and an N-terminal Cys. An N-terminal Cys can be formed by
enzymatic cleavage, commonly using the Factor Xa and TEV
proteases. We show that thrombin can be used for the formation
of N-terminal Cys, providing another choice of reagents for ex-
pressed protein ligation. Proteins with N-terminal Cys can be ob-
tained by the convenient modiﬁcation of vectors with the putative
thrombin cleavage site LVPRG to LVPRC. Two example pro-
tein domains (Csk and Abl tyrosine kinase domain) with N-ter-
minal Cys are demonstrated using this method. The use of
thrombin protease to generate N-terminal Cys overcomes some
of the limitations of existing methods, making it generally useful
for expressed protein ligation and other biotechnological applica-
tions.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Expressed protein ligation (EPL) is a widely used protein-
engineering approach that allows recombinant and synthetic
polypeptides to be chemoselectively and regioselectively joined
together [1–3]. An important application is segmental labeling
especially for nuclear magnetic resonance (NMR), permitting
a wide range of structural mapping studies to be conducted.
In this strategy, a uniformly labeled recombinant protein frag-
ment is ligated to an unlabeled protein fragment [4–7]. Only a
portion of the newly formed protein is labeled, resulting in a
NMR spectrum containing a subset of the resonances from
the corresponding uniformly labeled sample. The expressed
protein ligation method involves the reaction of an N-terminal
protein segment having a C-terminal a-thioester with a C-ter-
minal protein segment having a N-terminal Cys residue [8].
Current methods to generate proteins with N-terminal Cys
use chemical synthesis, the self-cleaving of inteins [8] and pro-
teolysis [4] (Fig. 1). Chemical synthesis is limited to relatively
small peptides. The intein system can be used for introduction
of the N-terminal Cys for the C-terminal protein fragment [4].
The intein-mediated introduction of N-terminal Cys has sev-
eral limitations: (1) solution pH or temperature may need to*Corresponding author. Fax: +1 212 939 0863.
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tion; (2) in vivo degradation of the intein fusion protein may
lead to a low yield of the target protein; (3) not all target
proteins can be expressed with intein fusion and some of the
fusion proteins form inclusion bodies during the expression.
N-terminal Cys can also be formed by enzymatic cleavage of
a proteolytic leader sequence, using enzymes like Factor Xa
[4,9,10] or TEV [11,12] and such cleavage is eﬃcient in some,
but not all, cases. One of the simplest ways to generate a re-
combinant polypeptide containing an N-terminal Cys residue
is to introduce a Cys downstream to the initiating Met residue.
Once the translation step is completed, the endogeneous
methionyl aminopeptidases (MAP) removes the Met residue,
thereby generating in vivo a N-terminal Cys residue [13]. Some
studies claimed that cleavage was only partial, and side reac-
tions can limit the yield of target N-terminal Cys protein
[13,14].
In this communication, we describe another choice for the
formation of N-terminal Cys – demonstrating that proteins
with N-terminal Cys can be produced with thrombin. Throm-
bin is the most widely used enzyme to cleave the target proteins
from its fusion partner. Jenny et al. [15] have reviewed the use
of thrombin as a tool of cleavage and have demonstrated that
both thrombin and Factor Xa can hydrolyze a variety of pep-
tide bonds in proteins. The most commonly used cutting se-
quences are LVPRG or LVPRGS with cleavage after the
Arg residue. Proteins with N-terminal Cys can be obtained
conveniently by the modiﬁcation of vectors with thrombin
cleavage site LVPRG to LVPRC. The use of thrombin prote-
ase to generate N-terminal Cys overcomes some of the limita-
tions of existing methods in EPL, and should extend the
applications of EPL and other biotechnological applications.2. Materials and methods
The vector pH-MBP-T was modiﬁed from pMAL-c2X by adding
His6-tag in the N-terminal of MBP and mutating Factor Xa into a
thrombin cleavage site. The N-terminal His6-tag before maltose bind-
ing protein (MBP) was used to facilitate puriﬁcation [16]. Human Csk
kinase domain (residue 187–450) was ampliﬁed using primer 1 (5 0-
GAA TTC GGA TCC TGG GCC CTG AAC ATG AAG) and primer
2 (5 0-TGC TAC GTC GAC CTA CAG GTG CAG CTC GTG GGT),
and cloned into pH-MBP-T and further referred to as pH-MBP-T-
CKinase (Fig. 2). The plasmid with the Factor Xa cut site was ob-
tained by primer 3 (5 0-GTA GCA GGA TCC ATC GAG GGA
CGT TGC GGC GGC TGG GCC CTG AAC ATG) and primer 2
and named pH-MBP-Xa-CKinase. The plasmid with an LVPRC cut
site was obtained via the QuikChange [17] method using primer 4
(5 0-CGG GCT GGT TCC GCG TTG TTT CTA CCG TTC CGG
ATG GGC CCT G) and primer 5 (5 0-CAG GGC CCA TCC GGA
ACG GTA GAA ACA ACG CGG AAC CAG CCC G), and named
pH-MBP-TC-CKinase. Murine ABL tyrosine kinase domain geneblished by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic mechanism of expressed protein ligation. Expressed protein ligation is an extension of the native chemical ligation method in which
two unprotected synthetic peptide are chemically ligated together. Protein 1 can be expressed as intein fusions and cleaved from the intein with a
variety of thiols to give the corresponding C-terminal a-thioester. Protein 2, containing N-terminal Cys, can be made by synthetic, N-terminal intein
fusion and proteolytic methods. At the ligation step, spontaneous intramolecular rearrangement generates a native peptide bond.
Fig. 2. Plasmids constructed and corresponding protein sequences in this study. The enzyme cleavage site is indicated by a down arrow.
1164 D. Liu et al. / FEBS Letters 582 (2008) 1163–1167(protein residues 230–500) was ampliﬁed using primer 6 (5 0-GGC
CGG ATC CCC CAA CTA CGA CAA GTG) and primer 7 (5 0-
GCG CGT CGA CTT AGG ATT CCT GGA ACA TGG TTT
CAA), and cloned into pH-MBP-T. This plasmid is referred to as
pH-MBP-T-AKinase and was modiﬁed with an LVPRC cut site using
primer 8 (5 0-GCT GGT TCC GCG TTG CTC CCC CAA CTA CG)
and primer 9 (5 0-CGT AGT TGG GGG AGC AAC GCG GAA CCA
GC) yielding H-MBP-TC-AKinase. The MBP gene was ampliﬁed and
cloned into pTWIN1 (New England Biolabs Inc.) vector using the Nde
I and Sap I restriction site to obtain the MBP-thioester. The plasmid
was named pTWIN1-MBP and the corresponding protein product
was named MBP-intein-CBD. All DNA sequences were veriﬁed using
standard DNA sequencing.
BL21 cells harboring one of the plasmids (pH-MBP-T-CKinase, pH-
MBP-TC-CKinase, pH-MBP-Xa-CKinase, pH-MBP-T-AKinase, pH-
MBP-TC-AKinase, and pTWIN1-MBP) were inoculated in 25 ml of
LB medium containing 100 lg/ml ampicillin and cultured at 37 C un-
til the optical density (OD600) reached 0.8. The resulting culture was
then used to inoculate 1 l of the LB medium. The cells were grown
at 37 C to density 0.8 and induced by adding 0.2 mM IPTG.
[U-15N] H-MBP-TC-CKinase protein was produced similarly, exceptthe cells were grown in M9 minimal media supplemented with 1 g/l
15NH4Cl as the sole nitrogen source. After overnight induction at
15 C, the cells were harvested by centrifugation at 5000 · g for
20 min at 4 C. The cells were re-suspended in 35 ml of buﬀer A
(50 mM Tris–HCl, pH 8.0, 250 mM NaCl), and lysed using French
Press. The insoluble cell debris was removed by centrifugation
(15000 · g) at 4 C for 20 min. For the puriﬁcation of the csk kinase
fragment, the supernatant was passed through a 10 ml TALON metal
aﬃnity column (GE Healthcare) charged with Co2+ ions at a ﬂow rate
of 1.0 ml/min. For the Abl kinase, Nickel-NTA beads charged with
Ni2+ ions was used. The column, immobilized with the overexpressed
target protein, was washed by 10· column volume of buﬀer A. The tar-
get fusion protein was eluted by adding 250 mM Imidazole to buﬀer A.
All of the fractions having the target fusion protein were pooled and
dialysed against the thrombin cleavage buﬀer (20 mM Tris–HCl, pH
8.4, 150 mM NaCl, 25 mM CaCl2) or Factor Xa cleavage buﬀer
(50 mM Tris–HCl, pH 8.0, 100 mM NaCl, 5 mM CaCl2), respectively.
To cleave 1 mg of fusion protein with the original LVPRG site, 10 unit
of human a-thrombin (Enzyme Research Laboratories) was used and
for the mutated LVPRG to LVPRC site, 20 unit of human a-thrombin
was used. Similarly, to cleave 1 mg of fusion protein with the Factor
Fig. 3. SDS–PAGE analysis of fusion expression of H-MBP-TC-
CKinase (lanes 1–4) and H-MBP-TC-AKinase (lanes 5–8). Lanes 1
and 5, whole cell lysate before IPTG induction; lanes 2 and 6, whole
cell lysate after IPTG induction; lanes 3 and 7, pellet fraction after
French Press treatment; lanes 4 and 8, soluble fraction after French
Press treatment.
Table 1
The molecular weight of the proteins used in the expressed protein
ligation experiments
Protein Calculated mass (Da) Observed mass (Da)
Csk CKinase 30296 30308
MBP (intein fusion) 42243 42242
MBP (kinase fusion) 43443 43410
Intein-CBD 27856 27840
MBP-intein-CBD 70082 70150
MBP-Ckinase ligation 72521 72565
D. Liu et al. / FEBS Letters 582 (2008) 1163–1167 1165Xa site, 20 unit of restriction grade Factor Xa (Novagen) was added.
All cleavage was conducted at 10 C and samples were collected at dif-
ferent time intervals to monitor the complete cleavage of the fusion
protein by running SDS–PAGE. HiTrap Q HP column was used for
the puriﬁcation of cleaved proteins. For the puriﬁcation of MBP-in-
tein-CBD, the clariﬁed cell extract was loaded to 10 ml of chitin beads
(New England Biolabs, S6651L) which pre-equilibrated with buﬀer A.
The column was washed with 50 ml of buﬀer A to remove the unbound
protein. The column bound with protein MBP-intein-CBD was stored
at 4 C for the ligation with kinase domain. The cleavage of the intein-
tag was induced by equilibrating the chitin beads to buﬀer A with
200 mM MESNA (2-mercaptoethanesulfonic acid). After 24 h of on-
column cleavage at room temperature, the target protein MBP with
C-terminal thioester was eluted from the column by 40 ml of buﬀer
A and concentrated to 0.5 mM. The protein ligation experiment was
conduced at room temperature for two days in buﬀer A with
200 mM MESNA, 1 mM EDTA. The ligation products were checked
by MALDI-TOF mass spectrum on an Applied Biosystems Voyager
DE Pro machine (Table 1).
NMR experiments were performed at 15 C on a Bruker 900 MHz
spectrometer equipped with a triple resonance cryo-probe. Protein
solutions were prepared in the following buﬀer conditions: 50 mM
Tris–HCl (pH 7.5), 10 mM DTT, 1.0 mM EDTA, 0.01% (w/v)
NaN3, 5% D2O and 0.1 mM DSS (4,4-dimethyl-4-silapentane-1-sulfo-
nate). 1H–15N heteronuclear single quantum coherence (HSQC) spec-
trum was collected with a 1H sweep width of 12626.263 Hz, with
1024 points, and at a 15N sweep width of 3284.072 Hz, 256 increments
[18]. Pulsed-ﬁeld gradient techniques with a WATERGATE pulse se-
quence were used for all H2O experiments.3. Results
The genes of Csk and Abl kinase domain were ampliﬁed
from full-length gene by PCR using primers designed to intro-
duce BamH I and Sal I sites immediately upstream and down-
stream of the gene, respectively. A similar method was used for
the cloning of Csk kinase with a Factor Xa cleavage site. The
cloned target gene in H-MBP-T vector is located downstream
from the malE gene, which encodes maltose-binding protein
(MBP). This results in the expression of a His6-tagged MBP-
fusion protein. The vector uses the strong Ptac promoter and
the translation initiation signals of MBP to express large
amounts of the fusion protein. The fusion protein is then puri-
ﬁed by one-step metal aﬃnity column.
Expression of the fusion genes in Escherichia coli was ana-
lyzed by SDS–PAGE (Fig. 3) for both Csk and Abl kinase.
The molecular weight of the H-MBP-T-CKinase and
H-MBP-T-AKinase is 72 kDa, which includes the molecular
weight of the cleaved H-MBP (42 kDa) and that of Csk and
Abl kinase (30 kDa). Lanes 1, 2 and 5, 6 show the SDS–
PAGE before and after induction for pH-MBP-TC-Ckinase
and pH-MBP-TC-Akinase with IPTG, respectively. The pres-
ence of an intense protein band around 72 kDa in lanes 2 and 6
(Fig. 3) clearly indicates that cells have expressed the fusionprotein. Lanes 3, 4 and 7, 8 show the insoluble and soluble
fractions in the lysate after cells were lysed using French Press
for both Csk and Abl kinase fusion proteins, respectively. Pres-
ence of very intense band around 72 kDa in lanes 4 and 8 com-
pared to lanes 3 and 7 indicates that most of the fusion
proteins (H-MBP-TC-CKinase and H-MBP-TC-Akinase) are
in the soluble fraction of the cell lysate. Although there are
some reports that the bacterial expression of tyrosine kinase
domain is diﬃcult [19,20], our results indicate that the fusion
expression system is suitable for expression of Csk kinase
and Abl kinase.
Since the fusion partner in the expression vector is a His6-
tagged N-terminal fragment of MBP, fusion proteins can be
puriﬁed by using a routine metal-chelating aﬃnity chromatog-
raphy procedure. As shown in Fig. 4, the fusion proteins were
puriﬁed to apparent homogeneity by one-step puriﬁcation,
using chelating aﬃnity chromatography. To test the eﬃciency
of the mutated thrombin cleavage site, the target fusion pro-
tein with the mutated thrombin site was incubated with throm-
bin. A small aliquot of samples was taken at diﬀerent time
interval to run a SDS–PAGE. Fig. 4a shows the cleavage of
H-MBP-TC-CKinase at 0, 1, 2, 4, 6, 8 and 24 h by thrombin.
Lane 8 shows that the cleavage mixture after 24 h incubation
with thrombin results only in speciﬁc cleavage of the kinase
domain (30 kDa), and that the complete cleavage of
H-MBP-TC-CKinase can be achieved in 24 h. Thus, the target
fusion protein with a mutated cut sequence (LVPRC) can be
successfully cleaved without causing signiﬁcant non-speciﬁc
cleavage in the kinase domain. Similar results were obtained
for the H-MBP-TC-AKinase. Fig. 4b summarizes the cleavage
of the ﬁve fusion proteins. Note both the fusion proteins with a
regular thrombin cleavage site (LVPRG) and a mutated
thrombin cleavage site (LVPRC) were cleaved to completion
without any detectable non-speciﬁc cleavage after 24 h. On
the other hand, H-MBP-Xa-CKinase fusion protein, upon
Fig. 4. (a) SDS–PAGE analysis of H-MBP-TC-CKinase fusion
protein cleaved with thrombin at diﬀerent time interval. The cleavage
times are indicated on the top of the gel. (b) SDS–PAGE analysis of
thrombin or Factor Xa cleavage of the ﬁve fusion proteins. Protein
names are indicated at the top of the gel. The lanes marked as ‘‘B’’
indicates the fusion protein before the enzyme cleavage whereas the
lanes marked with ‘‘A’’ indicate after thrombin or Factor Xa cleavage.
(c) SDS–PAGE analysis of protein ligation. Lane 1 shows the puriﬁed
the MBP protein with C-terminal a-thioester. Lane 2 shows the
puriﬁed Csk kinase domain with N-terminal Cys. Lane 3 shows the
mixture of MBP with kinase domain after ligation for 24 h. A band
corresponding to the ligation product appeared after 24 h of ligation.
The extent of ligation was estimated as 20% by SDS–PAGE.
Fig. 5. 1H–15N HSQC spectrum of Csk kinase domain with N-
terminal Cys. The protein sample (100 lM) was dissolved in 50 mM
Tris–HCl (pH 7.5), 10 mM DTT, 1.0 mM EDTA, 0.01% (w/v) NaN3,
5% D2O, 0.1 mM DSS (4,4-dimethyl-4-silapentane-1-sulfonate). The
spectrum was recorded at 900 MHz and 15 C.
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the fusion protein is not fully cleaved (Fig. 4b). A 1H–15N
HSQC spectrum (Fig. 5) of the Csk kinase domain with
N-terminal Cys was acquired to demonstrate the folding status
of this protein using the thrombin cleavage method. The
HSQC spectrum is well dispersed which suggests that the iso-
lated kinase domain is folded and well-structured.
We used MBP with C-terminal a-thioester to conﬁrm that
the protein products containing N-terminal Cys are active in
ligation. MBP was expressed as an intein-chitin binding fusion
protein and puriﬁed using chitin resin. Cleavage of MBP from
intein was carried out at room temperature, overnight, by
incubation of the fusion protein bound to chitin resin in col-
umn buﬀer containing buﬀer A and 200 mM MESNA. MBP(200 lM) and Csk kinase (400 lM) was ligated 24 h at room
temperature in buﬀer A containing 200 mM MESNA, with
200 mM MESNA, 1 mM EDTA.
Fig. 4c lane 1 shows the puriﬁed the MBP protein with C-
terminal a-thioester. Lane 2 shows the puriﬁed Csk kinase do-
main with N-terminal Cys. Lane 3 shows the mixture of MBP
with Kinase domain after ligation for 24 h. A band corre-
sponding to the ligation product appeared after 24 h of liga-
tion. The extent of ligation was typically 20% evaluated by
SDS–PAGE. The masses of the corresponding product (Table
1) are: Csk Kinase: 30308 (30296), MBP (from intein fusion):
42242 (42243), MBP (from kinase fusion): 43410 (43443), In-
tein-CBD, 27840 (27856), MBP-intein-CBD fusion protein:
70150 (70082), MBP-kinase ligation product: 72565 (72521),
(calculated theoretical value indicated in ( )). These results
demonstrate the N-terminal Cys prepared by thrombin cleav-
age can really be ligated with active a-thioester.4. Discussion
The optimum cleavage sequence for a-thrombin could have
the following nomenclature: (a) P4-P3-Pro-Arg-P1 0-P2 0, where
P3 and P4 are hydrophobic amino acids and P1 0 and P2 0 are
nonacidic amino acids or (b) P2-Arg-P1 0, where P2 or P1 0
are Gly. Though it has been shown that the hydrophobic P2
and P4 residues are essential for thrombin speciﬁcity, the apo-
lar P1 0 and P2 0 residues are also crucial [21]. Thrombin prefers
cleavage after P1, when the preceding residue is Arg rather
than Lys [22] and cleaves eﬃciently when the P4 position has
an aliphatic residue and the P2 position is a Pro, whereas no
favorable preference is necessary at the P3 position. Jenny
et al. have summarized the use of thrombin as the tool of cleav-
D. Liu et al. / FEBS Letters 582 (2008) 1163–1167 1167age and have demonstrated that thrombin can hydrolyze a
variety of peptide bonds in proteins [15]. These ﬁndings
suggest that the thrombin cleavage is not restricted to the
sequence LVPRG or LVPRGS, although this sequence is opti-
mized for the cleavage eﬃciency. Our results show that we can
use this method to make N-terminal Cys as illustrated by Csk
kinase and Abl kinase domains without signiﬁcant reduction
of thrombin eﬃciency.
Proteins with N-terminal Cys are useful in a wide range of
biotechnological applications ranging from expressed protein
ligation to site-speciﬁc N-terminal labeling. To the best of
our knowledge, thrombin cleavage using this mutated cleavage
site has not been previously reported for the generation of
N-terminal Cys of the C-terminal domain for the expressed
protein ligation. It is advantageous to use this mutated throm-
bin sequence for the generation of N-terminal Cys as thrombin
cleavage sites are present in most of the commercial vectors
and the thrombin protease is quite economical. The use of
thrombin protease to generate N-terminal Cys overcomes
some of the limitations of existing methods, and this should
make it generally useful for expressed protein ligation and
other biotechnological applications.
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